ストックスクリーナーアプリを入手
4.76
4.23%
-0.21
アフターアワーズ：
4.84
0.08
+1.68%
前日終値:
$4.97
開ける：
$4.91
24時間の取引高:
867.45K
Relative Volume:
2.66
時価総額：
$230.96M
収益：
-
当期純損益:
$-54.19M
株価収益率:
-1.845
EPS:
-2.58
ネットキャッシュフロー:
$-37.34M
1週間 パフォーマンス:
-7.03%
1か月 パフォーマンス:
-9.16%
6か月 パフォーマンス:
-24.68%
1年 パフォーマンス:
-34.34%
1日の値動き範囲:
$4.68
$4.96
1週間の範囲:
$4.68
$5.18
52週間の値動き範囲:
$3.05
$8.45
Abeona Therapeutics Inc Stock (ABEO) Company Profile
名前
Abeona Therapeutics Inc
セクター
電話
646-813-4701
住所
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
ABEO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
4.76 | 230.96M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-05 | 開始されました | Oppenheimer | Outperform |
| 2024-07-03 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-30 | 開始されました | Stifel | Buy |
| 2020-11-11 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | 開始されました | B. Riley FBR | Buy |
| 2020-02-10 | 開始されました | SVB Leerink | Outperform |
| 2019-12-10 | 再開されました | Cantor Fitzgerald | Neutral |
| 2019-08-15 | ダウングレード | Maxim Group | Buy → Hold |
| 2019-08-12 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-06-27 | 開始されました | Mizuho | Buy |
| 2018-10-12 | 開始されました | Mizuho | Buy |
| 2018-06-05 | 開始されました | Seaport Global Securities | Buy |
| 2017-11-08 | 開始されました | SunTrust | Buy |
| 2017-10-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-10-11 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2017-10-10 | 開始されました | Citigroup | Buy |
| 2017-10-05 | 繰り返されました | Maxim Group | Buy |
| 2017-09-15 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-07-18 | 繰り返されました | Maxim Group | Buy |
| 2017-06-22 | 再開されました | Jefferies | Buy |
| 2017-01-06 | 開始されました | Jefferies | Buy |
| 2016-09-29 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Abeona Therapeutics Inc (ABEO) 最新ニュース
Abeona Therapeutics CEO sells shares worth $119,500 - Investing.com
Abeona Therapeutics (NASDAQ:ABEO) Upgraded by StockNews.com to Hold Rating - MarketBeat
What is Zacks Small Cap’s Estimate for ABEO Q3 Earnings? - Defense World
What is Zacks Small Cap’s Forecast for ABEO Q1 Earnings? - Defense World
Equities Analysts Set Expectations for ABEO Q1 Earnings - Defense World
Trend Tracker for (ABEO) - news.stocktradersdaily.com
What is HC Wainwright’s Forecast for ABEO Q1 Earnings? - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Given Buy Rating at HC Wainwright - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Upgraded to Hold at StockNews.com - Defense World
Abeona Therapeutics: Positive Outlook Amid FDA Hopes - MSN
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript - Insider Monkey
Abeona planning potential US launch of pz-cel to treat RDEB - Epidermolysis Bullosa News
Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... - Yahoo Finance
Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... By GuruFocus - Investing.com Canada
Abeona Therapeutics Reports 2024 Financial Results - TipRanks
Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat - Investing.com India
Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat By Investing.com - Investing.com UK
Abeona Therapeutics targets $2B revenue potential for pz-cel amid U.S. launch preparations - MSN
Oppenheimer maintains Abeona Therapeutics Outperform rating - Investing.com India
Abeona Therapeutics® Reports Full Year 2024 Financial - GlobeNewswire
Abeona Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ABEONA THERAPEUTICS INC. SEC 10-K Report - TradingView
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory - Bluefield Daily Telegraph
Abeona Strengthens to $98M Cash Position as FDA Decision for Pz-cel Approaches - StockTitan
(ABEO) On The My Stocks Page - news.stocktradersdaily.com
Abeona Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Abeona Therapeutics at Leerink’s Global Healthcare Conference: Launch Plans for PZcell - Investing.com Canada
Abeona Therapeutics (ABEO) Projected to Post Earnings on Monday - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Coverage Initiated at Oppenheimer - Defense World
Oppenheimer Initiates Coverage of Abeona Therapeutics (ABEO) with Outperform Recommendation - MSN
This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Oppenheimer Initiates Coverage of Abeona Therapeutics (LSE:0H7R) with Outperform Recommendation - Nasdaq
Trading (ABEO) With Integrated Risk Controls - Stock Traders Daily
Oppenheimer sets Abeona stock Outperform with $16 target By Investing.com - Investing.com Canada
Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference - GlobeNewswire
When Abeona Therapeutics Takes the Stage: CEO's Upcoming Leerink Conference Presentation - StockTitan
Abeona Therapeutics announces new employee inducement grants - Yahoo Finance
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
How Abeona Therapeutics Is Structuring Compensation to Attract New Talent - StockTitan
Abeona Therapeutics Insider Stock Sales Prove Timely As Market Valuation Descends To US$232m - Simply Wall St
StockNews.com Downgrades Abeona Therapeutics (NASDAQ:ABEO) to Sell - MarketBeat
How the (ABEO) price action is used to our Advantage - Stock Traders Daily
Cell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.
Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Down 6.8% in January - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Abeona Therapeutics (NASDAQ:ABEO) - MarketBeat
Abeona Therapeutics’ (ABEO) Buy Rating Reaffirmed at HC Wainwright - Defense World
Epidermolysis Bullosa Market Expected to rise, 2034 | Amryt - openPR
Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Update - Defense World
StockNews.com Upgrades Abeona Therapeutics (NASDAQ:ABEO) to Hold - Armenian Reporter
abrdn plc Has $1.25 Million Stock Holdings in Abeona Therapeutics Inc (NASDAQ:ABEO) - MarketBeat
Abeona Therapeutics Inc (ABEO) 財務データ
収益
当期純利益
現金流量
EPS
1.05%
1.79%
大文字化:
|
ボリューム (24 時間):